Methods to find out the expression of activated genes

被引:3
作者
Cekan S.Z. [1 ]
机构
[1] Karolinska Institute, Department of Woman and Child Health, Karolinska University Hospital, 17176 Stockholm
关键词
Differential Display; Test Preparation; Test cDNA; Representational Difference Analysis; Transcription Initiation Complex;
D O I
10.1186/1477-7827-2-68
中图分类号
学科分类号
摘要
This review deals with the methods of identifying genes that have been activated by inner or outer impulses. The activation and subsequent expression of a gene can be detected by its transcription into a corresponding messenger ribonucleic acid (mRNA). Principles of the methods for identification of individual activated genes, as well as groups of activated genes are described, the former methods being mostly based on subtractive hybridization and serial analysis of gene expression (SAGE), the latter on microarrays. Examples of gene activation by the hormone 17betaestradiol (E2) are given. © 2004 Cekan; licensee BioMed Central Ltd.
引用
收藏
页数:11
相关论文
共 58 条
  • [1] Cekan S.Z., Quantitative analysis of steroid hormone receptors and their messenger ribonucleic acids, J. Lab. Clin. Med., 124, pp. 606-622, (1994)
  • [2] Stavreus-Evers A., Cekan S.Z., Quantitative measurements of steroid receptors and their messenger ribonucleic acids with a special emphasis on polymerase chain reaction, J. Lab. Clin. Med., 137, pp. 383-397, (2001)
  • [3] Cekan S.Z., Genes and transcription factors, including nuclear receptors: Methods of studying their interactions, J. Lab. Clin. Med., 140, pp. 215-227, (2002)
  • [4] White R.E., Darkow D.J., Lang J.L., Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism, Circ. Res., 77, pp. 936-942, (1995)
  • [5] Pines A., Averbuch M., Fisman E.Z., Rosano G.M.C., The acute effects of sublingual 17 beta-estradiol on the cardiovascular system, Maturitas, 33, pp. 81-85, (1999)
  • [6] Darblade B., Pendaries C., Krust A., Dupont S., Fouque M.J., Rami J., Chambon P., Bayard F., Arnal J.F., Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor, Circ. Res., 8, pp. 413-419, (2002)
  • [7] Gooren L.J., Toorians A.W., Significance of oestrogens in male (patho)physiology, Ann. Endocrinol. (Paris), 64, pp. 126-135, (2003)
  • [8] Mack W.J., Hameed A.B., Xiang M., Roy S., Slater C.C., Stanczyk F.Z., Lobo R.A., Liu C.R., Liu C.H., Hodis H.N., Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: Results from the estrogen in the prevention of atherosclerosis trial, Atherosclerosis, 168, pp. 91-98, (2003)
  • [9] Thijs A., van Baal W.M., van der Mooren M.J., Kenemans P., Drager A.M., Huijgens P.C., Stehouwer C.D.A., Effects of hormone replacement therapy on blood platelets, Eur. J. Clin. Invest., 32, pp. 613-618, (2002)
  • [10] Pereda C.A., Hannon R.A., Naylor K.E., Eastell R., The impact of subcutaneous oestradiol implants on biochemical markers of bone and bone mineral density in postmenopausal women, BJOG, 109, pp. 812-820, (2002)